AI & Machine Learning

Are MRI Site Effects Spatially Structured and Interpretable?
Tech & Innovation Are MRI Site Effects Spatially Structured and Interpretable?

The fundamental pursuit of identifying reliable biomarkers for neurological and psychiatric conditions in the year 2026has necessitated the aggregation of neuroimaging data across numerous global research sites and scanner platforms. While this collaborative approach provides the statistical power

Health100 App Earns Data Privacy and Security Accreditation
Tech & Innovation Health100 App Earns Data Privacy and Security Accreditation

The rapid digitization of medical records has created a complex paradox where patients demand instant, on-the-go access to their health data while simultaneously fearing the security vulnerabilities inherent in mobile technology. In a landscape where high-profile data breaches often make headlines,

Nova Scotia Invests $1 Million to Scale Biomanufacturing
Management & Regulatory Nova Scotia Invests $1 Million to Scale Biomanufacturing

The global manufacturing landscape is currently undergoing a seismic shift as traditional chemical processes are being replaced by biological systems that utilize living organisms to create essential materials. Nova Scotia is positioning itself at the forefront of this industrial revolution by

Can Elsie Solve the Clinical Laboratory Labor Shortage?
Tech & Innovation Can Elsie Solve the Clinical Laboratory Labor Shortage?

The persistent scarcity of qualified clinical laboratory professionals has reached a critical juncture where innovative technological interventions are no longer optional for maintaining operational stability and ensuring patient safety. In the current landscape of 2026, healthcare facilities are

Eight Custom Software Trends Are Reshaping Health Tech
Tech & Innovation Eight Custom Software Trends Are Reshaping Health Tech

The traditional image of healthcare as a paper-heavy, bureaucratic machine has been dismantled by a wave of digital tools that prioritize efficiency and patient outcomes above all else. As providers navigate an environment defined by high patient expectations and tightening regulatory requirements,

FDA and EMA Set New Compliance Standards for AI in Trials
Tech & Innovation FDA and EMA Set New Compliance Standards for AI in Trials

The landscape of pharmaceutical innovation has undergone a seismic shift as regulatory bodies transition from passive observers of technology to active architects of digital integrity, marking a definitive end to the era of unregulated machine learning experimentation in clinical development. For

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later